The Changing Demographics and Epidemiology of Hepatocellular Carcinoma
- PMID: 39608950
- DOI: 10.1016/j.cld.2024.08.001
The Changing Demographics and Epidemiology of Hepatocellular Carcinoma
Abstract
The epidemiology of hepatocellular carcinoma (HCC) has shifted significantly in the last 2 decades with non-viral etiologies such as metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease on the rise. Key factors include the global obesity epidemic and the resurgence of alcohol use disorder, both of which were exacerbated by the coronavirus disease 2019 pandemic. While these non-viral etiologies of HCC are becoming the leading cause in developed countries, the potential impact of immigration patterns on Hepatitis B virus epidemiology cannot be ignored. The risk of HCC remains significant in individuals with cirrhosis and viral hepatitis after curative treatments.
Keywords: ALD; Epidemiology; HBV; HCC; HCV; MASH; MASLD.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure R. Gujarathi: None; J.A. Klein: None; C-Y. Liao: Consultant for: AstraZeneca, Genentech, Histosonics, Incyte, Ipsen, QED, Transthera, Boston Scientific. Speaker for: AstraZeneca, Incyte. A. Pillai: On the medical advisory board of Exelixis, Genentech, AstraZeneca, Eisai Inc. and on the safety advisory board for Replimune.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
